Mind Medicine Valuation
| MNMD Stock | USD 6.70 0.25 3.88% |
At this time, the firm appears to be undervalued. Mind Medicine secures a last-minute Real Value of $7.61 per share. The latest price of the firm is $6.7. Our model forecasts the value of Mind Medicine from analyzing the firm fundamentals such as Return On Equity of -0.68, shares owned by insiders of 1.49 %, and Current Valuation of 235.75 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mind Medicine's valuation include:
Undervalued
Today
Please note that Mind Medicine's price fluctuation is moderately volatile at this time. Calculation of the real value of Mind Medicine is based on 3 months time horizon. Increasing Mind Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mind stock is determined by what a typical buyer is willing to pay for full or partial control of Mind Medicine. Since Mind Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mind Stock. However, Mind Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.7 | Real 7.61 | Target 8.0 | Hype 6.47 | Naive 7.59 |
The real value of Mind Stock, also known as its intrinsic value, is the underlying worth of Mind Medicine Company, which is reflected in its stock price. It is based on Mind Medicine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mind Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mind Medicine helps investors to forecast how Mind stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mind Medicine more accurately as focusing exclusively on Mind Medicine's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mind Medicine's intrinsic value based on its ongoing forecasts of Mind Medicine's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mind Medicine's closest peers. If more than one evaluation category is relevant for Mind Medicine we suggest using both methods to arrive at a better estimate.
Mind Medicine Cash |
|
Mind Valuation Drivers Correlation
Many accounts on the financial statements of Mind Medicine are highly interrelated and sometimes correlated. Consequently, when conducting Mind's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Mind
Click cells to compare fundamentals
Mind Valuation Trend
Comparing Mind Medicine's enterprise value against its market capitalization is a good way to estimate the value of Mind Medicine uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Mind Medicine Total Value Analysis
Mind Medicine is now expected to have valuation of 235.75 M with market capitalization of 487.63 M, debt of 21.85 M, and cash on hands of 105.74 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mind Medicine fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
235.75 M | 487.63 M | 21.85 M | 105.74 M |
Mind Medicine Asset Utilization
One of the ways to look at asset utilization of Mind is to check how much profit was generated for every dollar of assets it reports. Mind Medicine secures a negative usage of assets of -0.3 %, losing $0.003044 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Mind Medicine shows how discouraging it operates for each dollar spent on its assets.Mind Medicine Ownership Allocation
Mind Medicine maintains a total of 75.37 Million outstanding shares. Over half of Mind Medicine's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Mind Medicine Profitability Analysis
Net Loss for the year was (108.68 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mind Medicine's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mind Medicine and how it compares across the competition.
About Mind Medicine Valuation
The stock valuation mechanism determines Mind Medicine's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mind Medicine. We calculate exposure to Mind Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mind Medicine's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.8 M | -3 M |
Mind Medicine Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mind Medicine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 704.6 M |
Mind Medicine Current Valuation Indicators
Valuation refers to the process of determining the present value of Mind Medicine and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mind we look at many different elements of the entity such as Mind's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mind Medicine, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mind Medicine's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mind Medicine's worth.Complementary Tools for Mind Stock analysis
When running Mind Medicine's price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |